Learn More


 
MBA Tools
MBA Glossary

 


iShares NASDAQ Biotechnology I - IBB - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

 

iShares NASDAQ Biotechnology I - SIC # 6722

Ticker Exchange SIC # Website Latest Ticker
IBB Nasdaq 6722 http://www.ishares.com/ 180.08 Stock Down -1.93

Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company:

Latest Headlines for iShares NASDAQ Biotechnology I

Biotechnology ETF Investing 101 - May 20th, 2013 8:28 am
1929, 1987, and 2013: Three of a Kind? - May 17th, 2013 9:01 am
IBB, AMGN, CELG, ALXN: ETF Inflow Alert - May 14th, 2013 9:52 am
Issuer Spotlight: iShares - May 13th, 2013 5:00 am
Best ETFs In 2013: DBJP, Tesla-Fueled QCLN - May 12th, 2013 10:00 pm
Positive Prognosis for Biotech ETFs - May 10th, 2013 12:10 pm
Why I Am A Biotech Permabull - May 7th, 2013 1:44 pm
Investors Clamor for Generic Drug ETF - May 6th, 2013 2:20 pm
IBB, AMGN, CELG, ALXN: ETF Inflow Alert - May 6th, 2013 9:07 am
The Big Picture Charts Look Positive - Apr 29th, 2013 7:10 am
The Big Picture Charts Look Positive - Apr 29th, 2013 7:10 am


View All Current Headlines >>

Bookmark and Share
facebooktwitter